Ann: Imugene Corporate Presentation, page-188

I have over the last few days been reading all the feedback from those who attended the presentations, I also logged into and watched the online presentation....

My take is that there is obviously a focus on CF33, and compared to previous other drug developments it is running at break neck speed. I am hopeful that the past week's events and next weeks Hobart event will ultimately provide some support for the valuation of IMU.

Yuman Fong is I believe there to explain / present his life's work, If I knew nothing about him and listened to what he has been able to achieve in his life combined with the current progress of CF33 and had the opportunity to get on his coattails by being a shareholder in IMU then I would.

We current shareholders, who have been on the journey for a long time, for better or worse have the distinct advantage of all the previous announcements, presentations and interviews.

Thank you for all the opinions posted over the last few days in regards to the events. You can't say the the management are not giving it their all in terms of promoting the stock

DYOR and if you can't or don't want to you shouldn't buy the shares